Some biological opportunities only exist once in a lifetime. Stem cells from the umbilical cord and placenta can only be collected at birth, while genetic analyses may in some cases identify risks or provide explanations long before symptoms appear.
Cellaviva helps people preserve biological material and access advanced genetic analyses, with a focus on fertility, transplantation, future health, and medical decision-making over time.
As the market for health testing and longevity services continues to grow, it has become increasingly difficult to distinguish scientifically grounded services from commercial concepts lacking clinical foundation. Making informed decisions requires both reliable data and expertise you can trust.
Cellaviva was founded in 2014 by researchers from Karolinska Institutet and is built on scientific expertise and a long-term clinical perspective. All services are performed through certified laboratories, with quality-assured processes, continuously monitored cryogenic storage, and medical laboratory oversight.
The company operates under the supervision of the Swedish Health and Social Care Inspectorate (IVO) and follows established regulatory and clinical standards.














